Twitter   LinkedInFacebookRSS  
Browse Top Headlines

Search Text
Start Date
End Date

Teasing Apart Hope From Hype For Liquid Biopsy


Diagnostics World News | Liquid biopsies are emerging as rapid and cost-effective tools for the management of cancer patients, making it difficult to sniff out hope from hype.

Predicting Immunotherapy Response And Toxicity In Melanoma


Diagnostics World News | There is an urgent need to identify biomarkers that accurately predict for treatment response and guide the selection of novel combination therapies for patients who acquire resistance.

Digital Pathology Making Inroads Around The World


Diagnostics World News | Pathologists around the world over—65,000 of them in 163 countries at last count—appear enamored of a free and easy-to-use digital pathology platform that allows slides to be aggregated irrespective of the scanner that created them.

Young Scientists Present Diagnostic Solutions At Molecular Medicine Tri-Conference


Diagnostics World News | During the Molecular Medicine Tri-Conference, dozens of early-career scientists presented their solutions to real-world clinical, scientific, and organizational problems at the event's poster viewing sessions.

Point-Of-Care Testing And Diagnostics In Vietnam


Diagnostics World News | At the Molecular Medicine Tri-Conference in San Francisco, Gerald Kost gave insight into point-of-care testing's impact in Central Vietnam.

Variant Interpretation Then And Now: Moving Toward Rigorous, Consistent Workflows


Diagnostics World Contributed Commentary | Variant interpretation has come a long way since the days when single-gene or even single-variant tests represented the cutting edge in clinical labs. With the explosion of next-generation sequencing (NGS) and other multiplex-friendly technologies, variant analysts who could once easily perform manual review of every mutation, now face an onslaught of data.

ASHG Issues Position Statement On Recontact For Genetic Results


Diagnostics World News Brief | The American Society of Human Genetics, along with several co-signing organizations, issued a position statement today outlining whether, and to what extent, there is a responsibility to recontact genetic and genomic research participants.

Bill Gates, Jeff Bezos Donate Millions To Alzheimer's Research


Diagnostics World News Brief | The Bill and Melinda Gates Foundation and the Day One Fund, launched by Amazon CEO Jeff Bezos, have teamed up to donate $15 million to the Alzheimer's Drug Discovery Foundation (ADDF) in support of its Diagnostics Accelerator research program. This latest donation brings the total program funding to $50 million since its launch in July 2018.

From Nobel Prize-Worthy To Quaint: PCR’s Past, Present, And Predicted Future


Diagnostics World News | Imagine a future in which polymerase chain reaction (PCR) is viewed as old-fashioned. In the meantime, researchers generate billions of copies of the sequence of interest in order to carry out experiments and procedures in fields like molecular biology, evolutionary biology, and medical diagnostics.

MinION Could Reduce Huntington's Disease Diagnosis To Days Instead Of Weeks


Diagnostics World News Brief | The world's first genetic test for Huntington's disease using nanopore-based DNA sequencing technology is now available at Guy's and St Thomas' NHS Foundation Trust.

Vela, Ortho, UC Berkley, And More: News From March 2019


Diagnostics World News | March featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Vela, Ortho, UC Berkley, and more.

Harnessing Machine Learning And Artificial Intelligence To Accelerate Discovery In Diagnostics


Diagnostics World News | As several diagnostics advances have found their footing in AI, researchers have been able to churn out massive amounts of data. However, results have revealed challenges in scaling up analysis. At the Molecular Medicine Tri-Conference in San Francisco, a multidisciplinary cadre of thought leaders tackled this issue, sharing their latest applications of these technologies to large-scale data to streamline diagnostics.

Mass Spec Disrupts Molecular Diagnostics


Diagnostics World | Molecular diagnostics is a field overdue for disruptive technologies. Recent developments in mass spectrometry provide opportunities to more effectively and systematically gain insight on protein levels in biological fluids.

CareDx Files Patent Infringement Lawsuit Against Natera


Diagnostics World News Brief | CareDx today announced that it has filed a patent infringement suit against Natera in the United States District Court for Delaware.

UVA Health System Shifts To Multimedia-Enhanced Radiology Reports


Diagnostics World | At most provider organizations today, radiology reports are static, plain-text documents with the formatting pizzazz of a 1980s newspaper. The potential to improve communication is behind a movement at the University of Virginia Health System to popularize the use of interactive, multimedia radiology reports where “a picture is worth a thousand words.”

With Launch Of New CRISPR Company, Competition Extends To Diagnostics


Forbes | The gene editing technology CRISPR, which has already spawned several startups aiming to use the tool to develop new therapies, is now the inspiration for a new company in a less-crowded space: diagnostic testing.

Building A Credit Score For Health: Sapiens Data Science’s Approach To Precision Medicine


Diagnostics World News | Sapiens Data Science is offering a digital platform that provides a personalized 10-year mortality risk assessment, empowering people to take control of their health.

Blood Test Detects Progression Of Alzheimer’s Before Symptoms Surface


Diagnostics World | New research reveals that a blood test could help detect the progression of Alzheimer’s disease up to 16 years before the onset of symptoms, which scientists say could open doors for the testing of therapies.

Path to Personalized Healthcare Lined with Clinical Decision Support

| Diagnostics World News | Oncologists are challenged to keep up with the latest research on hundreds of different cancer types as well as evidence on actionable genetic mutations that make cancer care increasingly personalized. Delivering the best possible care also means multidisciplinary alignment to decide on the most suitable diagnostic tools to apply and settle on a treatment path with patients and their care team, according to Roche. The Roche cloud-based NAVIFY Tumor Board decision support software integrates and displays relevant aggregated data into a holistic patient dashboard to aid oncology care teams in reaching clinical care decisions.

St. Jude Analyzes Gut Microbiome To Predict Risk Of Infection For Patients During Chemotherapy


Diagnostics World | Researchers at St. Jude Children’s Research Hospital have analyzed the role of the gut microbiome in predicting whether children might develop infections prior to, during, and after chemotherapy.